CD274 and diffuse large B-cell lymphoma: As both Trp metabolites and PD‐L1 exhibit critical immunosuppressive roles in the TME, we provide potential strategies for Trp metabolism enzyme inhibitors in combination with anti‐PD‐L1 or other immunotherapeutic strategies in clinical DLBCL or NK/TCL treatment.